Jane Street’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$656K Buy
239,400
+139,400
+139% +$441K ﹤0.01% 7409
2025
Q4
$370K Buy
100,000
+76,000
+317% +$246K ﹤0.01% 8371
2025
Q3
$63.6K Buy
+24,000
New +$46.4K ﹤0.01% 10280
2025
Q1
Sell
-25,300
Closed -$55.7K 9708
2024
Q4
$55.7K Buy
+25,300
New +$59K ﹤0.01% 8939
2024
Q2
Sell
-44,400
Closed -$119K 9557
2024
Q1
$119K Buy
44,400
+7,300
+20% +$17.7K ﹤0.01% 8463
2023
Q4
$111K Buy
+37,100
New +$48.1K ﹤0.01% 8537
2023
Q3
Sell
-113,400
Closed -$158K 8816
2023
Q2
$158K Sell
113,400
-3,200
-3% -$4.47K ﹤0.01% 7789
2023
Q1
$185K Buy
116,600
+8,400
+8% +$43.4K ﹤0.01% 7898
2022
Q4
$674K Buy
108,200
+72,200
+201% +$516K ﹤0.01% 5640
2022
Q3
$241K Sell
36,000
-6,400
-15% -$44K ﹤0.01% 7896
2022
Q2
$270K Buy
+42,400
New +$240K ﹤0.01% 7772
2022
Q1
Sell
-81,400
Closed -$407K 10464
2021
Q4
$407K Buy
81,400
+7,600
+10% +$60.9K ﹤0.01% 7624
2021
Q3
$889K Buy
73,800
+62,000
+525% +$903K ﹤0.01% 6154
2021
Q2
$250K Sell
11,800
-6,900
-37% -$166K ﹤0.01% 8461
2021
Q1
$525K Buy
18,700
+3,600
+24% +$106K ﹤0.01% 6713
2020
Q4
$393K Sell
15,100
-4,500
-23% -$135K ﹤0.01% 6063
2020
Q3
$729K Sell
19,600
-36,500
-65% -$1.45M ﹤0.01% 4602
2020
Q2
$2.88M Buy
+56,100
New +$2.35M ﹤0.01% 2570
2020
Q1
Sell
-8,600
Closed -$513K 5462
2019
Q4
$513K Buy
+8,600
New +$387K ﹤0.01% 3659
2019
Q1
Sell
-9,000
Closed -$414K 5164
2018
Q4
$414K Sell
9,000
-8,700
-49% -$419K ﹤0.01% 3674
2018
Q3
$785K Buy
17,700
+12,200
+222% +$560K ﹤0.01% 3065
2018
Q2
$216K Buy
5,500
+1,000
+22% +$50.5K ﹤0.01% 4480
2018
Q1
$325K Sell
4,500
-6,200
-58% -$455K ﹤0.01% 3928
2017
Q4
$704K Sell
10,700
-14,100
-57% -$759K ﹤0.01% 2776
2017
Q3
$1.24M Buy
+24,800
New +$1.2M ﹤0.01% 2065
2017
Q2
Sell
-75,000
Closed -$2.65M 4456
2017
Q1
$2.65M Buy
+75,000
New +$1.72M 0.01% 1126

Other funds holding ESPR